Who are Azathioprine (AZA)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Azathioprine / 6 Mercaptopurine, addition of azathioprine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/azathioprine-aza.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Azathioprine (AZA) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Azathioprine (AZA) (Azathioprine (AZA)) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Purine analog immunosuppressant. Area: Immunology.

marketed Purine analog immunosuppressant Inosine monophosphate dehydrogenase (IMPDH), purine synthesis pathway Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Azathioprine (AZA) (Azathioprine (AZA)) — University Hospital Schleswig-Holstein. Azathioprine is a purine analog prodrug that is converted to 6-mercaptopurine, which inhibits purine synthesis and suppresses T-cell and B-cell proliferation.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Azathioprine (AZA) TARGET	Azathioprine (AZA)	University Hospital Schleswig-Holstein	marketed	Purine analog immunosuppressant	Inosine monophosphate dehydrogenase (IMPDH), purine synthesis pathway
Azathioprine / 6 Mercaptopurine	Azathioprine / 6 Mercaptopurine	PIBD-Net	marketed	Purine analog immunosuppressant	Hypoxanthine-guanine phosphoribosyltransferase (HGPRT), inosine monophosphate dehydrogenase (IMPDH)
addition of azathioprine	addition of azathioprine	Védrines, Philippe, M.D.	marketed	Purine analog immunosuppressant	Inosine monophosphate dehydrogenase (IMPDH), hypoxanthine-guanine phosphoribosyltransferase (HGPRT)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Purine analog immunosuppressant class)

PIBD-Net · 1 drug in this class
University Hospital Schleswig-Holstein · 1 drug in this class
Védrines, Philippe, M.D. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Azathioprine (AZA) — Competitive Intelligence Brief. https://druglandscape.com/ci/azathioprine-aza. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab